Laporan Laba Rugi (TTM)
Laporan Laba Rugi Alterity Therapeutics Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 2 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 5 | 5 |
| Change (%) | 99.99 | 7,657.17 | 98.71 | 5.48 | 5.20 | 3.20 | 3.10 | 0.26 | 0.26 | -11.98 | -13.61 | -6.19 | -6.60 | 8.57 | 7.89 | -3.67 | -3.81 | 23.02 | 18.71 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 7.60 | -6.20 | -6.61 | 6.33 | 5.95 | -5.05 | -5.32 | -6.29 | -6.71 | -5.29 | -5.59 | -11.06 | -12.44 | -1.73 | -1.76 | -7.79 | -8.44 | -14.76 | -17.32 | |
| % of Revenue | 2,713.35 | 1,459.86 | 17.65 | 8.30 | 8.36 | 8.42 | 7.75 | 7.12 | 6.65 | 6.19 | 6.66 | 7.28 | 6.90 | 6.47 | 5.86 | 5.33 | 5.10 | 4.86 | 3.37 | 2.34 |
| Gross Operating Profit | -0 | -0 | 2 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 |
| Change (%) | 4.07 | -569.74 | 121.29 | 5.41 | 5.13 | 3.96 | 3.81 | 0.76 | 0.76 | -12.42 | -14.18 | -5.81 | -6.17 | 9.28 | 8.49 | -3.44 | -3.56 | 24.94 | 19.96 | |
| % of Revenue | -2,613.35 | -1,359.86 | 82.35 | 91.70 | 91.64 | 91.58 | 92.25 | 92.88 | 93.35 | 93.81 | 93.34 | 92.72 | 93.10 | 93.53 | 94.14 | 94.67 | 94.90 | 95.14 | 96.63 | 97.66 |
| SG&A | 4 | 5 | 7 | 7 | 8 | 7 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 6 | 6 | 5 |
| Change (%) | 21.90 | 23.44 | 3.87 | 11.07 | -3.14 | -26.24 | 1.10 | -3.35 | -3.46 | -1.02 | -1.03 | -7.58 | -8.21 | 5.70 | 5.40 | 13.12 | 11.60 | -4.41 | -4.62 | |
| % of Revenue | 31,234.17 | 19,037.20 | 302.94 | 158.36 | 166.74 | 153.53 | 109.74 | 107.62 | 103.75 | 99.89 | 112.33 | 128.68 | 126.77 | 124.59 | 121.30 | 118.49 | 139.14 | 161.42 | 125.43 | 100.78 |
| R&D | 10 | 10 | 11 | 12 | 13 | 13 | 14 | 15 | 15 | 16 | 14 | 13 | 12 | 12 | 15 | 19 | 18 | 18 | 16 | 14 |
| Change (%) | 0.30 | 10.46 | 9.47 | 3.89 | 3.74 | 5.69 | 5.39 | 3.40 | 3.29 | -8.10 | -8.81 | -5.32 | -5.61 | 29.03 | 22.50 | -1.72 | -1.76 | -9.99 | -11.10 | |
| % of Revenue | 71,949.56 | 36,082.30 | 513.81 | 283.06 | 278.78 | 274.92 | 281.56 | 287.81 | 296.82 | 305.78 | 319.27 | 337.01 | 340.17 | 343.77 | 408.56 | 463.86 | 473.22 | 483.31 | 353.64 | 264.84 |
| OpEx | 15 | 16 | 18 | 20 | 21 | 21 | 20 | 21 | 21 | 21 | 20 | 19 | 17 | 16 | 20 | 24 | 24 | 24 | 22 | 20 |
| Change (%) | 6.71 | 14.39 | 7.09 | 6.46 | 1.26 | -5.74 | 4.00 | 1.48 | 1.46 | -6.32 | -6.75 | -6.07 | -6.46 | 22.47 | 18.35 | 1.32 | 1.31 | -8.56 | -9.36 | |
| % of Revenue | 106,068.69 | 56,593.90 | 834.55 | 449.77 | 453.94 | 436.93 | 399.09 | 402.56 | 407.48 | 412.37 | 438.87 | 473.72 | 474.34 | 475.05 | 535.89 | 587.82 | 618.28 | 651.15 | 484.02 | 369.57 |
| Operating Income | -15 | -16 | -16 | -15 | -16 | -16 | -15 | -16 | -16 | -16 | -15 | -15 | -14 | -13 | -16 | -20 | -20 | -21 | -18 | -15 |
| Change (%) | 6.62 | 0.86 | -5.38 | 6.74 | 0.14 | -8.39 | 4.30 | 1.89 | 1.85 | -4.51 | -4.72 | -6.04 | -6.43 | 26.18 | 20.75 | 2.35 | 2.29 | -14.29 | -16.67 | |
| % of Revenue | -105,968.74 | -56,493.91 | -734.55 | -349.77 | -353.94 | -336.93 | -299.09 | -302.56 | -307.48 | -312.37 | -338.87 | -373.72 | -374.34 | -375.05 | -435.89 | -487.82 | -518.28 | -551.15 | -384.02 | -269.57 |
| Interest Expense | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| Net Income | -15 | -16 | -16 | -15 | -14 | -13 | -13 | -13 | -14 | -14 | -14 | -14 | -13 | -12 | -16 | -19 | -19 | -20 | -16 | -12 |
| Change (%) | 9.79 | -3.26 | -3.37 | -6.46 | -6.91 | -1.82 | -1.85 | 5.64 | 5.34 | -1.71 | -1.74 | -5.52 | -5.84 | 27.85 | 21.79 | 1.74 | 1.71 | -19.31 | -23.93 | |
| % of Revenue | -105,971.44 | -58,176.39 | -725.49 | -352.78 | -312.84 | -276.84 | -263.39 | -250.75 | -264.19 | -277.57 | -309.95 | -352.54 | -355.06 | -357.94 | -421.52 | -475.79 | -502.51 | -531.34 | -348.53 | -223.35 |
Source: Capital IQ
